Literature DB >> 33564491

Surgical, Ultrasound Guided Drainage, and Medical Management of Tuboovarian Abscesses.

Frank A Crespo1,2, Dervi Ganesh1, Kaming Lo1, Kevin Chin1, Paul Norris1, Nahida Chakhtoura1.   

Abstract

OBJECTIVE: To compare surgical, ultrasound guided drainage, and medical management of tuboovarian abscesses (TOA) and determine if different characteristics in patient presentation influence treatment and outcome.
METHODS: Retrospective cohort study of 158 patients admitted to Jackson Memorial Hospital between 2007 and 2012 with a TOA.
RESULTS: Patients treated with IV antibiotics (IV) alone were hospitalized for 5.59 days (SD 2.52), IV antibiotics and US guided drainage (IV/US) were hospitalized for 9.63 days (SD 7.58), and IV antibiotics and surgery (IV/surgery) were hospitalized for 8.14 days ((SD3.9), (P < 0.001)). A total of 52 patients were readmitted with TOA; 41.8% were treated with IV; 26.9% were readmitted with IV/US; 7.1% were readmitted with IV/surgery (P < 0.022). Patients with a TOA measuring 0-8 cm were hospitalized for 5.97 days (SD 4.24), while those greater than 8 cm were hospitalized for 7.71 days ((SD 4.69), (P < 0.029)). Patients treated with a triple antibiotic regimen were hospitalized for 8.42 days (SD 5.70) versus 5.8 days (SD 3.24) when receiving an alternative regimen (P < 0.002).
CONCLUSIONS: Longer hospitalization in patients treated uniformly with either triple antibiotics, ultrasound guided drainage, or surgery represents a delay in optimal treatment. Tailoring treatment plans based on patient presentation may allow for shorter hospital stays and improved morbidity.

Entities:  

Year:  2014        PMID: 33564491      PMCID: PMC7869844          DOI: 10.1155/2014/501729

Source DB:  PubMed          Journal:  ISRN Infect Dis        ISSN: 2090-8725


  8 in total

Review 1.  Trends in the management of pelvic abscesses.

Authors:  R Mirhashemi; W M Schoell; R Estape; R Angioli; H E Averette
Journal:  J Am Coll Surg       Date:  1999-05       Impact factor: 6.113

2.  Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens.

Authors:  S D Reed; D V Landers; R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

Review 3.  Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess.

Authors:  Catherine A Chappell; Harold C Wiesenfeld
Journal:  Clin Obstet Gynecol       Date:  2012-12       Impact factor: 2.190

4.  Tuboovarian abscesses: is size associated with duration of hospitalization & complications?

Authors:  Jason Dewitt; Angela Reining; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Obstet Gynecol Int       Date:  2010-05-24

5.  The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast.

Authors:  M C Kamenga; K M De Cock; M E St Louis; C K Touré; S Zakaria; J M N'gbichi; P D Ghys; K K Holmes; D A Eschenbach; H D Gayle
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

6.  Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study.

Authors:  C R Cohen; S Sinei; M Reilly; E Bukusi; D Eschenbach; K K Holmes; J O Ndinya-Achola; J Bwayo; V Grieco; W Stamm; J Karanja; J Kreiss
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

7.  Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess.

Authors:  S G McNeeley; S L Hendrix; M M Mazzoni; D C Kmak; S B Ransom
Journal:  Am J Obstet Gynecol       Date:  1998-06       Impact factor: 8.661

8.  Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses.

Authors:  N Goharkhay; U Verma; F Maggiorotto
Journal:  Ultrasound Obstet Gynecol       Date:  2007-01       Impact factor: 7.299

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.